330 related articles for article (PubMed ID: 24770611)
1. Addressing statin adverse effects in the clinic: the 5 Ms.
Katz DH; Intwala SS; Stone NJ
J Cardiovasc Pharmacol Ther; 2014 Nov; 19(6):533-42. PubMed ID: 24770611
[TBL] [Abstract][Full Text] [Related]
2. Initiation Patterns of Statins in the 2 Years After Release of the 2013 American College of Cardiology/American Heart Association (ACC/AHA) Cholesterol Management Guideline in a Large US Health Plan.
Olufade T; Zhou S; Anzalone D; Kern DM; Tunceli O; Cziraky MJ; Willey VJ
J Am Heart Assoc; 2017 May; 6(5):. PubMed ID: 28473405
[TBL] [Abstract][Full Text] [Related]
3. Understanding Patient Adherence and Concerns with STatins and MedicatION Discussions With Physicians (ACTION): A survey on the patient perspective of dialogue with healthcare providers regarding statin therapy.
Brinton EA
Clin Cardiol; 2018 Jun; 41(6):710-720. PubMed ID: 29749101
[TBL] [Abstract][Full Text] [Related]
4. Overcoming Challenges With Statin Therapy.
Spence JD; Dresser GK
J Am Heart Assoc; 2016 Jan; 5(1):. PubMed ID: 26819251
[No Abstract] [Full Text] [Related]
5. Biochemistry of Statins.
Egom EE; Hafeez H
Adv Clin Chem; 2016; 73():127-68. PubMed ID: 26975972
[TBL] [Abstract][Full Text] [Related]
6. Assessing potential population impact of statin treatment for primary prevention of atherosclerotic cardiovascular diseases in the USA: population-based modelling study.
Yang Q; Zhong Y; Gillespie C; Merritt R; Bowman B; George MG; Flanders WD
BMJ Open; 2017 Jan; 7(1):e011684. PubMed ID: 28119384
[TBL] [Abstract][Full Text] [Related]
7. Statin Safety and Associated Adverse Events: A Scientific Statement From the American Heart Association.
Newman CB; Preiss D; Tobert JA; Jacobson TA; Page RL; Goldstein LB; Chin C; Tannock LR; Miller M; Raghuveer G; Duell PB; Brinton EA; Pollak A; Braun LT; Welty FK;
Arterioscler Thromb Vasc Biol; 2019 Feb; 39(2):e38-e81. PubMed ID: 30580575
[TBL] [Abstract][Full Text] [Related]
8. The Risk of Hepatotoxicity, New Onset Diabetes and Rhabdomyolysis in the Era of High-Intensity Statin Therapy: Does Statin Type Matter?
Benes LB; Bassi NS; Davidson MH
Prog Cardiovasc Dis; 2016; 59(2):145-152. PubMed ID: 27503844
[TBL] [Abstract][Full Text] [Related]
9. Statin Intolerance.
Brown AS; Watson KE
Rev Cardiovasc Med; 2018; 19(S1):S9-S19. PubMed ID: 30207553
[TBL] [Abstract][Full Text] [Related]
10. Trends in Statin Use 2009-2015 in a Large Integrated Health System: Pre- and Post-2013 ACC/AHA Guideline on Treatment of Blood Cholesterol.
Harrison TN; Scott RD; Cheetham TC; Chang SC; Hsu JY; Wei R; Ling Grant DS; Boklage SH; Romo-LeTourneau V; Reynolds K
Cardiovasc Drugs Ther; 2018 Aug; 32(4):397-404. PubMed ID: 30062465
[TBL] [Abstract][Full Text] [Related]
11. Are statins really wonder drugs?
Grover HS; Luthra S; Maroo S
J Formos Med Assoc; 2014 Dec; 113(12):892-8. PubMed ID: 24231094
[TBL] [Abstract][Full Text] [Related]
12. Overcoming toxicity and side-effects of lipid-lowering therapies.
Wilkinson MJ; Laffin LJ; Davidson MH
Best Pract Res Clin Endocrinol Metab; 2014 Jun; 28(3):439-52. PubMed ID: 24840269
[TBL] [Abstract][Full Text] [Related]
13. Evidence supporting primary prevention of cardiovascular diseases with statins: Gaps between updated clinical results and actual practice.
Bruckert E; Ferrières J
Arch Cardiovasc Dis; 2014 Mar; 107(3):188-200. PubMed ID: 24613429
[TBL] [Abstract][Full Text] [Related]
14. A summary and critical assessment of the 2013 ACC/AHA guideline on the treatment of blood cholesterol to reduce atherosclerotic cardiovascular disease risk in adults: filling the gaps.
Lopez-Jimenez F; Simha V; Thomas RJ; Allison TG; Basu A; Fernandes R; Hurst RT; Kopecky SL; Kullo IJ; Mulvagh SL; Thompson WG; Trejo-Gutierrez JF; Wright RS
Mayo Clin Proc; 2014 Sep; 89(9):1257-78. PubMed ID: 25131697
[TBL] [Abstract][Full Text] [Related]
15. Primary Prevention With Statins: ACC/AHA Risk-Based Approach Versus Trial-Based Approaches to Guide Statin Therapy.
Mortensen MB; Afzal S; Nordestgaard BG; Falk E
J Am Coll Cardiol; 2015 Dec; 66(24):2699-2709. PubMed ID: 26700832
[TBL] [Abstract][Full Text] [Related]
16. Statin Prescribing in the Elderly: Special Considerations.
Leya M; Stone NJ
Curr Atheroscler Rep; 2017 Oct; 19(11):47. PubMed ID: 29019063
[TBL] [Abstract][Full Text] [Related]
17. Does statin therapy initiation increase the risk for myopathy? An observational study of 32,225 diabetic and nondiabetic patients.
Nichols GA; Koro CE
Clin Ther; 2007 Aug; 29(8):1761-70. PubMed ID: 17919557
[TBL] [Abstract][Full Text] [Related]
18. Nonadherence to statins: individualized intervention strategies outside the pill box.
Lansberg P; Lee A; Lee ZV; Subramaniam K; Setia S
Vasc Health Risk Manag; 2018; 14():91-102. PubMed ID: 29872306
[TBL] [Abstract][Full Text] [Related]
19. Individualized Risk Communication and Outreach for Primary Cardiovascular Disease Prevention in Community Health Centers: Randomized Trial.
Persell SD; Brown T; Lee JY; Shah S; Henley E; Long T; Luther S; Lloyd-Jones DM; Jean-Jacques M; Kandula NR; Sanchez T; Baker DW
Circ Cardiovasc Qual Outcomes; 2015 Nov; 8(6):560-6. PubMed ID: 26555123
[TBL] [Abstract][Full Text] [Related]
20. Current Controversies With Recent Cholesterol Treatment Guidelines.
Phillips E; Saseen JJ
J Pharm Pract; 2016 Feb; 29(1):15-25. PubMed ID: 26611871
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
